A public record of what regulators, marketplaces and plaintiffs actually did about supplement marketing claims, and which standard each action maps to. Every entry carries a date and a source. Nothing here is a prediction.
Our standards are admitted, not invented: a phrase enters the rubric because a regulator, a marketplace or a court moved first. This page is that source record, kept in public so anyone can check the reasoning, cite the date, and see when the ground shifted under a claim they are still running.
Two kinds of entry. The dated events below are checked against their source and restated in one plain sentence each. The FDA warning letters are pulled from the agency's public database each week and listed exactly as published: company, issue date, subject line, and a link to the letter itself. No new supplement-relevant letters are listed right now; the feed updates weekly.
The Federal Trade Commission sued over supplements marketed as treating depression, anxiety and ADHD.
The FDA issued 25 warning letters in a single week to sellers marketing supplements as equivalents of prescription GLP-1 drugs.
FDA WARNING-LETTER DATABASE →Amazon began matching every detail-page claim, backend search keywords included, against the Supplement Facts panel, with mismatched listings deactivated without human review.
256 food and consumer-packaged-goods class actions were filed in 2024, the highest annual count on record.
Supplement, over-the-counter and functional-food marketers received a formal Notice of Penalty Offenses, which exposes unsubstantiated claims to civil penalties of $53,088 per violation under the statutory schedule.
A peer-reviewed analysis found 88% of tested melatonin gummy products were mislabelled, with measured doses running from 74% to 347% of the amount stated on the label.
Read the entry, then read your listing. If an action names a claim family you are running, it is running on borrowed time. The claim rulings say what to write instead.
A warning letter starts a 15-business-day clock. The claims half of the reply is what we build: see warning-letter response.
Journalists, analysts and counsel are free to quote this record with attribution. The aggregate compliance data sits on the research page.
Run one ASIN through the free check and see the severity counts on your own listing, ruled against the same 81 standards this record feeds.